Shockwave Medical (NSDQ:SWAV) filed a common stock equity offering with the SEC priced at $75 million. The Santa Clara, Calif.–based company said in yesterday’s filing that at the assumed public offering price of $36.14 that was reported on Nov. 11, it expects to offer nearly 2.1 million shares of common stock. Shockwave said it anticipates approximately […]
Frequency Therapeutics prices $84m IPO
Frequency Therapeutics said yesterday that it priced its initial public offering at roughly $84 million. The 6-million-share offering priced at $14 per share and includes a 30-day underwriters option on another 900,000 shares that’s worth $12.6 million, the Woburn, Mass.-based company said. Get the full story at our sister site, Drug Delivery Business News.
Danaher dental spinout Envista closes $677m IPO
Envista (NYSE:NVST), the dental business spinout from Danaher (NYSE:DHR), last week closed its initial public offering at $677 million, including more than $88 million from the underwriters. Brea, Calif.-based Envista floated nearly 26.8 million shares at $22.00 apiece, grossing $588.9 million, plus more than 4.0 million shares in fully subscribed underwriters option. Net proceeds of about $643.4 million […]
Danaher dental spinout Envista prices $589m IPO
Envista (NYSE:NVST), the dental business spinout from Danaher (NYSE:DHR), yesterday priced its initial public offering at $589 million, sending its overall valuation well above the $3 billion mark. The spinout, announced in July 2018, will unite the Nobel Biocare, KaVo Kerr and Ormco dental brands under the Envista umbrella. The nearly 26.8-million-share flotation, at $22 per share, is for […]
Danaher dental spinout Envista preps $600m IPO
The dental business spinout at Danaher (NYSE:DHR), Envista, is gearing up for a $600 million initial public offering this week. The spinout, announced in July 2018, will unite the Nobel Biocare, KaVo Kerr and Ormco dental brands under the Envista umbrella. The newly public company, which employs some 12,000 workers, is headquartered in Brea, Calif. Envista […]
SmileDirect Club plunges after IPO
Shares in SmileDirectClub (NSDQ:SDC) regained some of their value this morning after closing down some -28% after their public debut yesterday. Nashville, Tenn.-based SmileDirectClub makes 3D-printed clear dental aligners designed to provide an alternative to traditional braces. The company floated 58.5 million shares at $23 apiece in its $1.35 billion initial public offering yesterday, only to […]
Satsuma Pharmaceuticals registers $75m IPO
Satsuma Pharmaceuticals has registered an initial public offering, seeking to raise $75 million, according to a regulatory filing. The South San Francisco-based company is working on STS101, a nasal powder version of dihydroergotamine for migraine. It intends to use the money to fund its Phase 3 safety and efficacy clinical trials for STS101, manufacturing costs, preparation for […]
Frequency Therapeutics registers $100m IPO
Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market […]
InMode pulls down $70m with IPO
InMode (NSDQ:INMD) yesterday closed its initial public offering, saying it grossed $70 million for the radiofrequency devices it’s developing for aesthetic medical procedures. Proceeds from the flotation of 5 million shares at $14 apiece are earmarked for hiring additional sales and marketing personnel and expanding those programs and for funding R&D, working capital and general […]
Quanterix prices IPO common stock at $60m
Quanterix today announced an initial public offering of nearly 2.4 million shares of common stock at $25.25 apiece for which it expects to gross $60 million. Billerica, Mass.-based Quanterix is developing a digital approach to immunoassays to allow single molecules to be counted. Its technology is used in the therapeutic areas of oncology, neurology, cardiology, […]
InMode prices IPO at $70m
InMode this week announced an initial public offering of 5 million shares, for which it expects to gross $70 million. Lake Forest, Calif.-based InMode is developing devices that use minimally invasive radio-frequency technology for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode set the floatation at $14 per share, giving underwriters a 30-day option to […]
- 1
- 2
- 3
- …
- 33
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube